Evidence map›Paper›PMID 32758681›Full record

ReviewProgress in retinal and eye research2021

Fundus autofluorescence imaging.

Steffen Schmitz-Valckenberg, Maximilian Pfau, Monika Fleckenstein, Giovanni Staurenghi, Janet R Sparrow, Almut Bindewald-Wittich, Richard F Spaide, Sebastian Wolf, Srinivas R Sadda, Frank G Holz

Open access · greenAbstract readReview
In one paragraph

Review in Progress in retinal and eye research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 122 citations in OpenAlex.

  1. Article
  2. Review
  3. Observational
  4. Article
  5. Article
  6. Review
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Steffen Schmitz-ValckenbergDepartment of Ophthalmology, University of Bonn, Bonn, Germany; John A. Moran Eye Center, University of Utah, Salt Lake City, USA.
Maximilian PfauDepartment of Ophthalmology, University of Bonn, Bonn, Germany; Department of Biomedical Data Science, Stanford University, USA.
Monika FleckensteinDepartment of Ophthalmology, University of Bonn, Bonn, Germany.
Giovanni StaurenghiDepartment of Biomedical and Clinical Science "Luigi Sacco", Luigi Sacco Hospital University of Milan, Italy.
Janet R SparrowDepartments of Ophthalmology and Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA.
Almut Bindewald-WittichDepartment of Ophthalmology, University of Bonn, Bonn, Germany; Augenheilkunde Heidenheim MVZ, Heidenheim, Germany.
Richard F SpaideVitreous Retina Macula Consultants of New York, New York, NY, USA.
Sebastian WolfDepartment of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Srinivas R SaddaDoheny Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, USA.
Frank G HolzDepartment of Ophthalmology, University of Bonn, Bonn, Germany. Electronic address: frank.holz@ukbonn.de.
University of Bonn · DEColumbia University Irving Medical Center · USUniversity of Bern · CHUniversity of California, Los Angeles · USUniversity of Milan · ITVitreous Retina Macula Consultants of New York · US

Funding

University of Utah, Core Vision Research GrantP30EY014800 · NEI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Bryan William Jones · 2005 to 2026
$14.6M
NEI NIH HHS P30 EY014800
6 · The paper itself

Abstract

Fundus autofluorescence (FAF) imaging is an in vivo imaging method that allows for topographic mapping of naturally or pathologically occurring intrinsic fluorophores of the ocular fundus. The dominant sources are fluorophores accumulating as lipofuscin in lysosomal storage bodies in postmitotic retinal pigment epithelium cells as well as other fluorophores that may occur with disease in the outer retina and subretinal space. Photopigments of the photoreceptor outer segments as well as macular pigment and melanin at the fovea and parafovea may act as filters of the excitation light. FAF imaging has been shown to be useful with regard to understanding of pathophysiological mechanisms, diagnostics, phenotype-genotype correlation, identification of prognostic markers for disease progression, and novel outcome parameters to assess efficacy of interventional strategies in chorio-retinal diseases. More recently, the spectrum of FAF imaging has been expanded with increasing use of green in addition to blue FAF, introduction of spectrally-resolved FAF, near-infrared FAF, quantitative FAF imaging and fluorescence life time imaging (FLIO). This article gives an overview of basic principles, FAF findings in various retinal diseases and an update on recent developments.

Indexed as

HumansOptical ImagingPhotoreceptor Cells, VertebrateRetinal DiseasesRetinal Pigment EpitheliumFluorescence life timeLipofuscinMacular pigmentQuantitativeRetinaRetinal pigment epitheliumScanning laser ophthalmoscopy

Identifiers

PMID32758681
PMCPMC12906268
OpenAlexW3046290090

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.